{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:12:08Z","timestamp":1789506728708,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128725","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:14:23Z","timestamp":1782789263000},"page":"128725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023"],"prefix":"10.1016","volume":"88","author":[{"given":"Tanya R.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren H.","family":"Zauche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige L.","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"McCullum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Hause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Shay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2026.128725_bb0005","article-title":"The U.S. COVID-19 vaccination program: a look back and future directions","volume":"42","author":"Hall","year":"2024","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2026.128725_bb0010","article-title":"Overview of U.S. COVID-19 vaccine safety surveillance systems","volume":"42","author":"Gee","year":"2024","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128725_bb0015","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.vaccine.2022.12.031","article-title":"The v-safe after vaccination health checker: active vaccine safety monitoring during CDC\u2019S COVID-19 pandemic response","volume":"41","author":"Myers","year":"2023","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128725_bb0020","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.vaccine.2023.11.061","article-title":"CDC COVID-19 vaccine pregnancy registry: design, data collection, response rates, and cohort description","volume":"42","author":"Madni","year":"2024","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2026.128725_bb0025","article-title":"Development of COVID-19 vaccine policy - United States, 2020-2023","volume":"42","author":"Oliver","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128725_bb0035","author":"U.S. Census Bureau"},{"key":"10.1016\/j.vaccine.2026.128725_bb0040","author":"U.S. Department of Housing and Urban Development"},{"key":"10.1016\/j.vaccine.2026.128725_bb0050","article-title":"As some states open COVID-19 vaccines to all, many others are still weeks away. Here\u2019s a timeline","author":"Howard","year":"2021","journal-title":"CNN"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128725_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","article-title":"First month of COVID-19 vaccine safety monitoring - United States, December 14, 2020-January 13, 2021","volume":"70","author":"Gee","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"31","key":"10.1016\/j.vaccine.2026.128725_bb0060","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.15585\/mmwr.mm7031e1","article-title":"COVID-19 vaccine safety in adolescents aged 12-17 years - United States, December 14, 2020-July 16, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"39","key":"10.1016\/j.vaccine.2026.128725_bb0065","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.15585\/mmwr.mm7039e4","article-title":"Safety monitoring of an additional dose of COVID-19 vaccine - United States, august 12-September 19, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5152","key":"10.1016\/j.vaccine.2026.128725_bb0070","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.15585\/mmwr.mm705152a1","article-title":"COVID-19 vaccine safety in children aged 5-11 years - United States, November 3-December 19, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128725_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.15585\/mmwr.mm7107e1","article-title":"Safety monitoring of COVID-19 vaccine booster doses among adults - United States, September 22, 2021-February 6, 2022","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128725_bb0080","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1473-3099(22)00054-8","article-title":"Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the vaccine adverse event reporting system and v-safe","volume":"22","author":"Rosenblum","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128725_bb0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.15585\/mmwr.mm7109e2","article-title":"Safety monitoring of COVID-19 vaccine booster doses among persons aged 12-17 years - United States, December 9, 2021-February 20, 2022","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"10.1016\/j.vaccine.2026.128725_bb0090","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.15585\/mmwr.mm7133a3","article-title":"Safety monitoring of Pfizer-BioNTech COVID-19 vaccine booster doses among children aged 5-11 years - United States, may 17-July 31, 2022","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128725_bb0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.15585\/mmwr.mm7202a5","article-title":"Safety monitoring of bivalent COVID-19 mRNA vaccine booster doses among children aged 5-11 years - United States, October 12-January 1, 2023","volume":"72","author":"Hause","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"23","key":"10.1016\/j.vaccine.2026.128725_bb0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.15585\/mmwr.mm7223a2","article-title":"Safety monitoring of mRNA COVID-19 vaccine third doses among children aged 6 Months-5 years - United States, June 17, 2022-may 7, 2023","volume":"72","author":"Hause","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"24","key":"10.1016\/j.vaccine.2026.128725_bb0120","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:47:38Z","timestamp":1789505258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":19,"alternative-id":["S0264410X26005347"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128725","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128725"}}